Thursday Feb 2 | Tri-cityherald.com
Summary Box: Merck swings to profit in 4th quarter
BACK IN BLACK: Higher sales of most key drugs and lower charges push Merck & Co.
Merck: REMICADE Win, Settlement on Vioxx
REMICADE, made by Merck ,A has been used in the treatment of inflammatory bowel disease for more than 12 years in the EU.A Now, the Committee for Medicinal Products for Human Use of the European Medicines Agency adopted a positive opinion recommending the use of REMICADE in the treatment of severely active ulcerative colitis in pediatric patients ... (more)
Merck to pay at least $21.8M to settle Canadian Vioxx lawsuits
Pharmaceutical giant Merck says it has reached an agreement to settle Canadian lawsuits related to its controversial pain medication Vioxx.
Summary Box: Merck settling Canadian Vioxx cases
VIOXX DEAL: Merck and lawyers for Canadian Vioxx users have struck a deal, awaiting approval by courts in provinces there, to end lawsuits filed by hundreds of people claiming harm from the drugmaker's recalled painkiller Vioxx.
Merck resolves Vioxx litigation in Canada
MRK.N ) on Thursday said it had reached a settlement to pay between $21.6 million and $36.5 million to resolve all claims in Canada relating to Vioxx, the painkiller it withdrew from the market in 2004 after it was linked to heart attacks and strokes.
Also on Topix